BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34621683)

  • 1. The Contribution of Physiological and Accelerated Aging to Cancer Progression Through Senescence-Induced Inflammation.
    Morales-Valencia J; David G
    Front Oncol; 2021; 11():747822. PubMed ID: 34621683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing.
    Mongiardi MP; Pellegrini M; Pallini R; Levi A; Falchetti ML
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
    Kang C
    Mol Cells; 2019 Dec; 42(12):821-827. PubMed ID: 31838837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
    Lau L; David G
    Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
    [No Abstract]   [Full Text] [Related]  

  • 7. SASP-Dependent Interactions between Senescent Cells and Platelets Modulate Migration and Invasion of Cancer Cells.
    Valenzuela CA; Quintanilla R; Olate-Briones A; Venturini W; Mancilla D; Cayo A; Moore-Carrasco R; Brown NE
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer.
    Banerjee P; Kotla S; Reddy Velatooru L; Abe RJ; Davis EA; Cooke JP; Schadler K; Deswal A; Herrmann J; Lin SH; Abe JI; Le NT
    Front Cardiovasc Med; 2021; 8():763930. PubMed ID: 34746270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages.
    Huang Y; Yang X; Meng Y; Shao C; Liao J; Li F; Li R; Jing Y; Huang A
    Cell Biosci; 2021 Sep; 11(1):173. PubMed ID: 34530917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Premature Senescence in Breast Cancer Treatment Strategy.
    Milczarek M
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Senescent Cells in the Bone Microenvironment.
    Farr JN; Fraser DG; Wang H; Jaehn K; Ogrodnik MB; Weivoda MM; Drake MT; Tchkonia T; LeBrasseur NK; Kirkland JL; Bonewald LF; Pignolo RJ; Monroe DG; Khosla S
    J Bone Miner Res; 2016 Nov; 31(11):1920-1929. PubMed ID: 27341653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases.
    Cuollo L; Antonangeli F; Santoni A; Soriani A
    Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33371508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Involvement of phenotype secretor of senescent cells in the development of cancer, aging and the diseases associated with age].
    González-Puertos VY; Maciel-Barón LÁ; Barajas-Gómez BA; López-Diazguerrero NE; Königsberg M
    Gac Med Mex; 2015; 151(4):491-500. PubMed ID: 26290026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
    Niklander SE; Lambert DW; Hunter KD
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and oral squamous cell carcinoma development: the role of cellular senescence.
    Niklander SE; Aránguiz P; Faunes F; Martínez-Flores R
    Front Oral Health; 2023; 4():1285276. PubMed ID: 37904749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.